AAAAAA

   
Results: 1-11 |
Results: 11
PHARMACOLOGICAL CHARACTERIZATION OF A NOVEL LONG-ACTING HISTAMINE H-1RECEPTOR ANTAGONIST, KAA-276
Authors: KOBAYASHI T TAKEHANA Y SHINAGAWA K TSUYUKI S TOKUTAKE Y SATO M MOMOSE D
Citation: T. Kobayashi et al., PHARMACOLOGICAL CHARACTERIZATION OF A NOVEL LONG-ACTING HISTAMINE H-1RECEPTOR ANTAGONIST, KAA-276, Biological & pharmaceutical bulletin, 21(4), 1998, pp. 350-355
EFFECTS OF INHALED KAA-276, A SELECTIVE HISTAMINE H-1 RECEPTOR ANTAGONIST, ON ANTIGEN-INDUCED AND HISTAMINE-INDUCED BRONCHOCONSTRICTION IN ANIMALS
Authors: KOBAYASHI T TAKEHANA Y SHINAGAWA K TSUYUKI S TOKUTAKE Y SATO M MOMOSE D
Citation: T. Kobayashi et al., EFFECTS OF INHALED KAA-276, A SELECTIVE HISTAMINE H-1 RECEPTOR ANTAGONIST, ON ANTIGEN-INDUCED AND HISTAMINE-INDUCED BRONCHOCONSTRICTION IN ANIMALS, Arzneimittel-Forschung, 48(8), 1998, pp. 826-831
O-METHYLASPARVENONE, A NITROGEN-FREE SEROTONIN ANTAGONIST
Authors: BOS M CANESSO R INOUEOHGA N NAKANO A TAKEHANA Y SLEIGHT AJ
Citation: M. Bos et al., O-METHYLASPARVENONE, A NITROGEN-FREE SEROTONIN ANTAGONIST, Bioorganic & medicinal chemistry, 5(12), 1997, pp. 2165-2171
QUANTIFICATION OF END-GROUPS IN ANIONICALLY POLYMERIZED POLY(METHYL METHACRYLATE)S BY PYROLYSIS-GAS CHROMATOGRAPHY
Authors: OHTANI H TAKEHANA Y TSUGE S
Citation: H. Ohtani et al., QUANTIFICATION OF END-GROUPS IN ANIONICALLY POLYMERIZED POLY(METHYL METHACRYLATE)S BY PYROLYSIS-GAS CHROMATOGRAPHY, Macromolecules, 30(9), 1997, pp. 2542-2545
TRANILAST INHIBITS THE PROLIFERATION, CHEMOTAXIS AND TUBE FORMATION OF HUMAN MICROVASCULAR ENDOTHELIAL-CELLS IN-VITRO AND ANGIOGENESIS IN-VIVO
Authors: ISAJI M MIYATA H AJISAWA Y TAKEHANA Y YOSHIMURA N
Citation: M. Isaji et al., TRANILAST INHIBITS THE PROLIFERATION, CHEMOTAXIS AND TUBE FORMATION OF HUMAN MICROVASCULAR ENDOTHELIAL-CELLS IN-VITRO AND ANGIOGENESIS IN-VIVO, British Journal of Pharmacology, 122(6), 1997, pp. 1061-1066
NEUTRALIZATION OF HIV TYPE-1 INFECTIVITY BY SERUM ANTIBODIES FROM A SUBSET OF AUTOIMMUNE PATIENTS WITH MIXED CONNECTIVE-TISSUE DISEASE
Authors: DOUVAS A TAKEHANA Y EHRESMANN G CHERNYOVSKIY T DAAR ES
Citation: A. Douvas et al., NEUTRALIZATION OF HIV TYPE-1 INFECTIVITY BY SERUM ANTIBODIES FROM A SUBSET OF AUTOIMMUNE PATIENTS WITH MIXED CONNECTIVE-TISSUE DISEASE, AIDS research and human retroviruses, 12(16), 1996, pp. 1509-1517
NEW ISOLATION METHODS AND POLYMERASE CHAIN-REACTION STRAIN DISCRIMINATION TECHNIQUES FOR NATURAL-PRODUCTS SCREENING PROGRAMS
Authors: OKUDA T YANAGISAWA A FUJIMORI F NISHIZUKA Y TAKEHANA Y SUGIYAMA M
Citation: T. Okuda et al., NEW ISOLATION METHODS AND POLYMERASE CHAIN-REACTION STRAIN DISCRIMINATION TECHNIQUES FOR NATURAL-PRODUCTS SCREENING PROGRAMS, Canadian journal of botany, 73, 1995, pp. 946-954
CROSS-REACTIVITY BETWEEN AUTOIMMUNE ANTI-U1 SNRNP ANTIBODIES AND NEUTRALIZING EPITOPES OF HIV-1 GP120 41/
Authors: DOUVAS A TAKEHANA Y
Citation: A. Douvas et Y. Takehana, CROSS-REACTIVITY BETWEEN AUTOIMMUNE ANTI-U1 SNRNP ANTIBODIES AND NEUTRALIZING EPITOPES OF HIV-1 GP120 41/, AIDS research and human retroviruses, 10(3), 1994, pp. 253-262
CALCIUM RECEPTORS AND ANTICENTROMERE ANTIBODIES IN THE PATHOGENESIS AND TREATMENT OF CREST
Authors: DOUVAS A TAKEHANA Y DUFFIN MD EHRESMANN GR
Citation: A. Douvas et al., CALCIUM RECEPTORS AND ANTICENTROMERE ANTIBODIES IN THE PATHOGENESIS AND TREATMENT OF CREST, Arthritis and rheumatism, 36(9), 1993, pp. 190000181-190000181
ANTI-U1 SNRNP ANTIBODIES CROSS-REACTING WITH HIV-1 EPITOPES INVOLVED IN NEUTRALIZATION
Authors: DOUVAS A TAKEHANA Y
Citation: A. Douvas et Y. Takehana, ANTI-U1 SNRNP ANTIBODIES CROSS-REACTING WITH HIV-1 EPITOPES INVOLVED IN NEUTRALIZATION, Arthritis and rheumatism, 36(5), 1993, pp. 5-5
A SCLERODERMA PATIENT WHO IS SIMULTANEOUSLY HIV-1-INFECTED AND HAS HIGH-TITER ANTI-U1 SNRNP ANTIBODIES
Authors: DOUVAS A EHRESMANN G TAKEHANA Y
Citation: A. Douvas et al., A SCLERODERMA PATIENT WHO IS SIMULTANEOUSLY HIV-1-INFECTED AND HAS HIGH-TITER ANTI-U1 SNRNP ANTIBODIES, Arthritis and rheumatism, 36(5), 1993, pp. 8-8
Risultati: 1-11 |